作者: E Haffen , H Javelot , P Fossati , G Meyer , P-M Llorca
DOI:
关键词:
摘要: French recommendations have been proposed for psychotropics use and possible adaptations during the SARS-CoV-2 epidemic. Between uncertainties linked to lack of data speculations about benefits against coronavirus, we propose here elements allowing base pharmacotherapeutic decisions potentially useful in Covid+ patients with psychiatric disorders.